TFX

Teleflex Incorporated 2006 Annual Report (10-K) Summary

Business Context and Reporting Period

Company: Teleflex Incorporated
Filing Type: Form 10-K
Reporting Period: Fiscal year ended December 31, 2006
Overview: Teleflex is a diversified industrial company specializing in specialty-engineered products for commercial, medical, and aerospace industries. Operations span 23 countries, with 57% of revenues generated outside the United States. The company is organized into three segments: Commercial (47% of revenue), Medical (33%), and Aerospace (20%).

Key Financial Metrics

Margins: Gross profit margin was approximately 29.2% in 2006. Segment operating profit increased 10% overall, driven by Aerospace and Medical segments, while Commercial segment margins declined.

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 5% to $2.65 billion, primarily driven by core growth (5% excluding currency, acquisitions, and divestitures). Aerospace grew 9%, Commercial 5%, and Medical 3%.
• Profitability: Net income remained relatively flat ($139.4M vs $138.8M) despite revenue growth, due to increased operating expenses (18.6% of revenue vs 17.9% in 2005) and a higher effective tax rate (24.72% vs 22.99%).
• Cost Structure: Materials, labor, and product costs improved to 70.7% of revenue from 71.8% in 2005. However, selling, engineering, and administrative expenses rose due to $10.4M in costs for a new information systems implementation in the Medical Segment and $6.8M in stock-based compensation expense under SFAS No. 123(R).
• Debt Reduction: Total debt decreased by approximately $112 million, funded by operating cash flows. Net debt to total capital ratio improved from 26% to 18%.
• Acquisitions: Acquired Taut, Inc. (Medical) for $28.0M and Ecotrans Technologies (Commercial) for $10.1M in November 2006.

Guidance, Outlook, Risks, and Unusual Items

• Restructuring: The company initiated a 2006 restructuring program across all segments with charges of $5.9M in 2006. Future costs are estimated between $3.0M and $5.4M over the next two quarters. A 2004 restructuring program continues with expected future costs of $1.6M to $3.2M in 2007.
• Impairments: Recorded a $1.0M goodwill impairment charge and a $7.4M charge for impaired minority investments and fixed assets in 2006.
• Outlook: Management expects core revenue growth to continue. The Medical Segment is implementing a new ERP system, with the first phase expected in Q3 2007, which may cause temporary inefficiencies.
• Risks: Key risks include cyclical demand in automotive and aerospace markets, foreign currency fluctuations (57% of revenue is non-U.S.), commodity price volatility (steel, plastic resins), and regulatory changes in healthcare reimbursement.
• Dividends: Quarterly dividend increased to $0.285 per share. Stock repurchases of $93.5M were completed in 2006 under an authorized plan.

Investor Verification Checklist

• Medical Segment ERP Implementation: Verify the timeline and cost impact of the new information systems implementation, which contributed to higher operating expenses in 2006.
• Commercial Segment Margins: Monitor the impact of commodity pricing and customer price reductions on the Commercial Segment's operating profit margin, which declined to 6.3%.
• Restructuring Execution: Track the realization of cost savings from the 2006 and 2004 restructuring programs against the estimated future costs.
• Foreign Currency Exposure: Assess the impact of the U.S. dollar strength on reported revenues and income, given the significant international exposure.
• Acquisition Integration: Review the performance of recent acquisitions (Taut, Inc. and Ecotrans) to ensure they meet revenue and profit expectations.